SCHEMBL8900693

SCHEMBL8900693

Clc1ccc2nc(N[RaH])ccc2c1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR3A P46098 1/20 0.42
HRH4 Q9H3N8 1/20 0.42
ALDH1A1 P00352 3/20 0.41
PDE3B Q13370 1/20 0.41
PDE3A Q14432 1/20 0.41
BACE1 P56817 2/20 0.41
CYP2A6 P11509 1/20 0.40
HRH3 Q9Y5N1 1/20 0.40
NPC1 O15118 2/20 0.39
RAB9A P51151 2/20 0.39
MCHR1 Q99705 1/20 0.39
HDAC1 Q13547 1/20 0.38
HDAC2 Q92769 1/20 0.38
NR4A2 P43354 1/20 0.37
F7 P08709 1/20 0.36
F3 P13726 1/20 0.36
DYRK1A Q13627 1/20 0.36
PIK3CG P48736 1/20 0.36
KDM4E B2RXH2 2/20 0.36
MEN1 O00255 2/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11108005 0.84 NCF1 (0.53) HTR3AHRH4ALDH1A1PDE3BPDE3A
SCHEMBL27834830 0.82 ALDH1A1 (0.56) HTR3AHRH4ALDH1A1PDE3BPDE3A
SCHEMBL8901397 0.78 BACE1 (0.53) ALDH1A1BACE1CYP2A6NPC1RAB9A
SCHEMBL8900732 0.78 PLAU (0.57) HTR3AALDH1A1BACE1HRH3DYRK1A
SCHEMBL9881000 0.78 HTR3A (0.42) HTR3AHRH4ALDH1A1PDE3BPDE3A
SCHEMBL18434128 0.77 MEN1 (0.50) ALDH1A1CYP2A6RAB9AKDM4EMEN1
SCHEMBL8902362 0.76 EGFR (0.45) NPC1RAB9AMCHR1MEN1MAPT
SCHEMBL5446666 0.75 CYP1A2 (0.49) HTR3AHRH4ALDH1A1BACE1MCHR1
SCHEMBL20913327 0.75 GRM4 (0.40) HTR3AHRH4ALDH1A1PDE3BPDE3A
SCHEMBL28402308 0.75 DYRK1A (0.56) ALDH1A1NPC1RAB9AHDAC1HDAC2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8188284-B2 2-aminoquinolines HOFFMAN-LA ROCHE INC. (US) 2012-05-29 US disclosed
US-20090227583-A1 2-AMINOQUINOLINES F. HOFFMANN-LA ROCHE AG, A SWISS COMPANY (CH) 2009-09-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090227583-A1 2-AMINOQUINOLINES HTR5A, HTR2C, HTR2B HTR3A 11/4885HRH4 80/4885ALDH1A1 2403/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.